Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jun;24(2):128-34.
doi: 10.3904/kjim.2009.24.2.128. Epub 2009 Jun 8.

Clinicopathologic characteristics of T-cell non-Hodgkin's lymphoma: a single institution experience

Ock Bae Ko  1 , Dae Ho Lee, Sang We Kim, Jung Shin Lee, Shin Kim, Jooryung Huh, Cheolwon Suh
Affiliations

Clinicopathologic characteristics of T-cell non-Hodgkin's lymphoma: a single institution experience

Ock Bae Ko et al. Korean J Intern Med. 2009 Jun.

Abstract

Background/aims: Although the incidence of T-cell non-Hodgkin's lymphoma (NHL) is higher in Far East Asia than in Western countries, its incidence and clinical course in Korea are not well-defined. Therefore, we assessed the relative frequency and clinical features of T-cell NHL in Korea.

Methods: We performed a retrospetcive analysis of 586 patients with NHL.

Results: 101 (17.2%) had T-cell NHL. The most frequent subtypes of T-cell NHL were extranodal NK/T-cell lymphoma, nasal type (NASAL), peripheral T-cell lymphoma, unspecified type (PTCL-U), and anaplastic large cell lymphoma, T/null cell, primary systemic type (ALCL). The seven pathological subtypes could be classified into three prognostic subgroups. When patients with the three most frequent subtypes were grouped together, their survival was reflected in the International Prognostic Index (IPI) scores. Univariate analysis of IPI elements and other clinical features showed that clinical stage and extranodal sites were significant predictors of survival. Cox multivariate analysis showed that the number of extranodal sites was the only independent prognostic indicator.

Conclusions: The relative frequency of T-cell NHL seems to be decreasing in Korea, although NASAL remains frequent. Korean patients with ALCL appear to have an unfavorable prognosis. Large-scale studies are warranted for Korean patients with T-cell NHL.

Keywords: Lymphoma; Peripheral; T-cell.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Histology of T-cell NHL. NASAL, extranodal NK/T-cell lymphoma, nasal; PTCL-U, peripheral T-cell lymphoma, unspecified; ALCL, anaplastic large cell lymphoma, T/null cell, primary systemic type; T-LBL, precursor T-cell lymphoblastic lymphoma; AITL, angioimmunoblastic T-cell lymphoma; ETTL, enteropathy-type T-cell lymphoma; ALCL-C, ALCL-cutaneous.
Figure 2
Figure 2
Overall survival of all patients.
Figure 3
Figure 3
Overall survival (OS) according to histology. The seven pathological subtypes observed could be classified into three prognostic subgroups (favorable, intermediate, and unfavorable) with respect to the OS. NASAL, extranodal NK/T-cell lymphoma, nasal; PTCL-U, peripheral T-cell lymphoma, unspec-ified; ALCL, anaplastic large cell lymphoma, T/null cell, primary systemic type; T-LBL, precursor T-cell lymphoblastic lymphoma; AITL, angioimmunoblastic T-cell lymphoma; ETTL, enteropathy-type T-cell lymphoma; ALCL-C, ALCL-cutaneous.
Figure 4
Figure 4
Overall survival according to the International Prognostic Index (IPI) score. Low-risk, IPI score 0, 1; low-intermediate risk, IPI score 2; high-intermediate risk, IPI score 3; high-risk, IPI score 4, 5.
See this image and copyright information in PMC

References

    1. Cancer facts and figures [Internet] American Cancer Society. [Cited 2008]. Available from: www.cancer.org .
    1. Muller A, Ihorst G, Mertelsmann R, Engelhardt M. Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol. 2005;84:1–12. - PubMed
    1. Cancer incidence, mortality and prevalence worldwide, version 1.0 IARC Cancer Base No.5 [Internet] IARC. [Cited 2001]. Available from: http://www-dep.iarc.fr/globocan.htm .
    1. The international Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictvie model for aggressive non-Hodgkin's lymphoma. N Engl J Med. 1993;329:987–994. - PubMed
    1. Ko YJ, Kim CW, Park CS, et al. Classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma. Cancer. 1998;83:806–812. - PubMed

MeSH terms

LinkOut - more resources